vs

Side-by-side financial comparison of CPS TECHNOLOGIES CORP (CPSH) and PRECISION OPTICS CORPORATION, INC. (POCI). Click either name above to swap in a different company.

CPS TECHNOLOGIES CORP is the larger business by last-quarter revenue ($8.2M vs $7.4M, roughly 1.1× PRECISION OPTICS CORPORATION, INC.). CPS TECHNOLOGIES CORP runs the higher net margin — 0.2% vs -24.2%, a 24.3% gap on every dollar of revenue. On growth, PRECISION OPTICS CORPORATION, INC. posted the faster year-over-year revenue change (62.8% vs 38.3%). Over the past eight quarters, PRECISION OPTICS CORPORATION, INC.'s revenue compounded faster (18.5% CAGR vs 17.8%).

Lesaka Technologies is a South-African financial technology company that is listed on the NASDAQ and Johannesburg Stock Exchange. Lesaka’s primary focus is on financial inclusion, offering financial services to previously underserved communities and merchants.

Century Precision Optics is an American lens manufacturing firm. It was founded in 1948 in North Hollywood, California as Century Photo Optics. Steven Manios Sr. purchased the company in 1973 and created many of the optics. Century Optics makes a variety of digital, broadcast, projection, and industrial lenses. They have offices in Hauppauge, New York and Van Nuys, California.

CPSH vs POCI — Head-to-Head

Bigger by revenue
CPSH
CPSH
1.1× larger
CPSH
$8.2M
$7.4M
POCI
Growing faster (revenue YoY)
POCI
POCI
+24.4% gap
POCI
62.8%
38.3%
CPSH
Higher net margin
CPSH
CPSH
24.3% more per $
CPSH
0.2%
-24.2%
POCI
Faster 2-yr revenue CAGR
POCI
POCI
Annualised
POCI
18.5%
17.8%
CPSH

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
CPSH
CPSH
POCI
POCI
Revenue
$8.2M
$7.4M
Net Profit
$12.6K
$-1.8M
Gross Margin
14.9%
2.8%
Operating Margin
-1.2%
-23.6%
Net Margin
0.2%
-24.2%
Revenue YoY
38.3%
62.8%
Net Profit YoY
101.3%
-83.6%
EPS (diluted)
$0.00
$-0.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CPSH
CPSH
POCI
POCI
Q4 25
$8.2M
$7.4M
Q3 25
$8.8M
$6.7M
Q2 25
$8.1M
$6.2M
Q1 25
$7.5M
$4.2M
Q4 24
$5.9M
$4.5M
Q3 24
$4.2M
$4.2M
Q2 24
$5.0M
$4.7M
Q1 24
$5.9M
$5.2M
Net Profit
CPSH
CPSH
POCI
POCI
Q4 25
$12.6K
$-1.8M
Q3 25
$208.0K
$-1.6M
Q2 25
$103.8K
$-1.4M
Q1 25
$96.0K
$-2.1M
Q4 24
$-995.2K
$-969.7K
Q3 24
$-1.0M
$-1.3M
Q2 24
$-954.3K
$-1.4M
Q1 24
$-143.2K
$-317.1K
Gross Margin
CPSH
CPSH
POCI
POCI
Q4 25
14.9%
2.8%
Q3 25
17.1%
14.2%
Q2 25
16.5%
12.9%
Q1 25
16.4%
10.0%
Q4 24
-4.6%
23.6%
Q3 24
-12.3%
26.6%
Q2 24
-4.6%
21.7%
Q1 24
15.3%
35.5%
Operating Margin
CPSH
CPSH
POCI
POCI
Q4 25
-1.2%
-23.6%
Q3 25
3.1%
-23.9%
Q2 25
1.7%
-21.9%
Q1 25
1.7%
-48.7%
Q4 24
-22.2%
-20.1%
Q3 24
-35.0%
-29.7%
Q2 24
-26.1%
-28.8%
Q1 24
-4.4%
-4.9%
Net Margin
CPSH
CPSH
POCI
POCI
Q4 25
0.2%
-24.2%
Q3 25
2.4%
-24.5%
Q2 25
1.3%
-22.7%
Q1 25
1.3%
-50.1%
Q4 24
-16.8%
-21.4%
Q3 24
-24.6%
-31.2%
Q2 24
-19.0%
-29.9%
Q1 24
-2.4%
-6.0%
EPS (diluted)
CPSH
CPSH
POCI
POCI
Q4 25
$0.00
$-0.23
Q3 25
$0.01
$-0.21
Q2 25
$0.01
$-0.19
Q1 25
$0.01
$-0.30
Q4 24
$-0.07
$-0.15
Q3 24
$-0.07
$-0.21
Q2 24
$-0.07
$-0.23
Q1 24
$-0.01
$-0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CPSH
CPSH
POCI
POCI
Cash + ST InvestmentsLiquidity on hand
$13.2M
$881.5K
Total DebtLower is stronger
$1.6M
Stockholders' EquityBook value
$24.6M
$9.3M
Total Assets
$29.5M
$22.9M
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CPSH
CPSH
POCI
POCI
Q4 25
$13.2M
$881.5K
Q3 25
$4.3M
$1.4M
Q2 25
$3.4M
$1.8M
Q1 25
$3.0M
$2.5M
Q4 24
$4.3M
$212.4K
Q3 24
$5.7M
$635.6K
Q2 24
$7.1M
$405.3K
Q1 24
$8.7M
$925.1K
Total Debt
CPSH
CPSH
POCI
POCI
Q4 25
$1.6M
Q3 25
$1.8M
Q2 25
$1.9M
Q1 25
$2.1M
Q4 24
$8.1K
$2.1M
Q3 24
$20.1K
$2.1M
Q2 24
$31.9K
$2.2M
Q1 24
$43.5K
$2.3M
Stockholders' Equity
CPSH
CPSH
POCI
POCI
Q4 25
$24.6M
$9.3M
Q3 25
$15.1M
$10.9M
Q2 25
$14.9M
$12.3M
Q1 25
$14.7M
$13.2M
Q4 24
$14.5M
$9.5M
Q3 24
$15.4M
$10.1M
Q2 24
$16.4M
$10.1M
Q1 24
$17.3M
$11.3M
Total Assets
CPSH
CPSH
POCI
POCI
Q4 25
$29.5M
$22.9M
Q3 25
$20.4M
$22.4M
Q2 25
$19.4M
$19.8M
Q1 25
$19.2M
$19.6M
Q4 24
$18.9M
$17.5M
Q3 24
$19.2M
$17.2M
Q2 24
$20.1M
$16.9M
Q1 24
$21.2M
$18.3M
Debt / Equity
CPSH
CPSH
POCI
POCI
Q4 25
0.17×
Q3 25
0.16×
Q2 25
0.16×
Q1 25
0.16×
Q4 24
0.00×
0.22×
Q3 24
0.00×
0.21×
Q2 24
0.00×
0.22×
Q1 24
0.00×
0.21×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CPSH
CPSH
POCI
POCI
Operating Cash FlowLast quarter
$243.6K
$-256.1K
Free Cash FlowOCF − Capex
$-487.0K
FCF MarginFCF / Revenue
-5.9%
Capex IntensityCapex / Revenue
8.9%
Cash ConversionOCF / Net Profit
19.34×
TTM Free Cash FlowTrailing 4 quarters
$-479.6K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CPSH
CPSH
POCI
POCI
Q4 25
$243.6K
$-256.1K
Q3 25
$1.1M
$78.2K
Q2 25
$649.3K
$-569.2K
Q1 25
$-1.3M
$-1.9M
Q4 24
$-3.5M
$-786.8K
Q3 24
$-1.2M
$-318.6K
Q2 24
$-1.0M
$-976.0K
Q1 24
$128.9K
$-214.2K
Free Cash Flow
CPSH
CPSH
POCI
POCI
Q4 25
$-487.0K
Q3 25
$876.8K
Q2 25
$476.4K
$-615.5K
Q1 25
$-1.3M
$-2.0M
Q4 24
$-4.5M
$-816.6K
Q3 24
$-1.3M
$-343.0K
Q2 24
$-1.6M
$-987.6K
Q1 24
$-134.5K
$-322.7K
FCF Margin
CPSH
CPSH
POCI
POCI
Q4 25
-5.9%
Q3 25
10.0%
Q2 25
5.9%
-10.0%
Q1 25
-17.9%
-47.8%
Q4 24
-75.3%
-18.0%
Q3 24
-29.8%
-8.2%
Q2 24
-31.8%
-20.9%
Q1 24
-2.3%
-6.2%
Capex Intensity
CPSH
CPSH
POCI
POCI
Q4 25
8.9%
Q3 25
2.0%
Q2 25
2.1%
0.7%
Q1 25
1.2%
3.0%
Q4 24
16.8%
0.7%
Q3 24
1.9%
0.6%
Q2 24
11.0%
0.2%
Q1 24
4.5%
2.1%
Cash Conversion
CPSH
CPSH
POCI
POCI
Q4 25
19.34×
Q3 25
5.05×
Q2 25
6.25×
Q1 25
-13.05×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CPSH
CPSH

Segment breakdown not available.

POCI
POCI

Systems Manufacturing$5.2M70%
Other$1.1M15%
Ross Optical Industries$1.0M14%

Related Comparisons